Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer Genomics and Diagnostics, Epigenetics and DNA Methylation, Bioinformatics and Genomic Networks, and Lung Cancer Treatments and Mutations.
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
Clinical Targeted Next-Generation Panel Sequencing Reveals <i>MYC</i> Amplification Is a Poor Prognostic Factor in Osteosarcoma
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer
Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis
Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project
Tumor Mutational Burden and <i>PTEN</i> Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer
Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Abstract 562: Oncovirus detection and integration analysis from human tumor samples using targeted massively parallel sequencing
Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors
Landscape of Genomic Alterations in Pituitary Adenomas
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
Oncogenic mutations in cervical cancer
Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor<i>MYBL1</i>
Mutations in Hedgehog pathway genes in fetal rhabdomyomas
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway
Integrative Genomic Analysis Implicates Gain of <i>PIK3CA</i> at 3q26 and <i>MYC</i> at 8q24 in Chronic Lymphocytic Leukemia
Germline copy number variation associated with Mendelian inheritance of CLL in two families